These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18036553)

  • 1. A comparative study of mechanisms of surfactant inhibition.
    Gunasekara L; Schoel WM; Schürch S; Amrein MW
    Biochim Biophys Acta; 2008 Feb; 1778(2):433-44. PubMed ID: 18036553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary surfactant function is abolished by an elevated proportion of cholesterol.
    Gunasekara L; Schürch S; Schoel WM; Nag K; Leonenko Z; Haufs M; Amrein M
    Biochim Biophys Acta; 2005 Oct; 1737(1):27-35. PubMed ID: 16216549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A spreading technique for forming film in a captive bubble.
    Putz G; Walch M; Van Eijk M; Haagsman HP
    Biophys J; 1998 Nov; 75(5):2229-39. PubMed ID: 9788918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.
    Holm BA; Enhorning G; Notter RH
    Chem Phys Lipids; 1988 Nov; 49(1-2):49-55. PubMed ID: 3233711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer.
    López-Rodríguez E; Ospina OL; Echaide M; Taeusch HW; Pérez-Gil J
    Biophys J; 2012 Oct; 103(7):1451-9. PubMed ID: 23062337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The surface-associated surfactant reservoir in the alveolar lining.
    Schürch S; Qanbar R; Bachofen H; Possmayer F
    Biol Neonate; 1995; 67 Suppl 1():61-76. PubMed ID: 7647159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-A.
    Zuo YY; Tadayyon SM; Keating E; Zhao L; Veldhuizen RA; Petersen NO; Amrein MW; Possmayer F
    Biophys J; 2008 Sep; 95(6):2779-91. PubMed ID: 18539636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of biophysical surface properties and change in ultrastructures of exogenous pulmonary surfactant by albumin or fibrinogen.
    Park J; Bae CW; Choi YM
    J Korean Med Sci; 1998 Apr; 13(2):123-30. PubMed ID: 9610611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidylcholine sensitizes lipid extracts of pulmonary surfactant to inhibition by serum proteins.
    Cockshutt AM; Possmayer F
    Biochim Biophys Acta; 1991 Oct; 1086(1):63-71. PubMed ID: 1954245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function.
    Wang Z; Schwab U; Rhoades E; Chess PR; Russell DG; Notter RH
    Tuberculosis (Edinb); 2008 May; 88(3):178-86. PubMed ID: 18155644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein SP-B counteracts inhibition of pulmonary surfactant by serum proteins.
    Friedrich W; Schmalisch G; Stevens PA; Wauer RR
    Eur J Med Res; 2000 Jul; 5(7):277-82. PubMed ID: 10903187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
    Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
    Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation and structure of surface films: captive bubble surfactometry.
    Schürch S; Green FH; Bachofen H
    Biochim Biophys Acta; 1998 Nov; 1408(2-3):180-202. PubMed ID: 9813315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
    Strayer DS; Herting E; Sun B; Robertson B
    Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of humidity on the stability of lung surfactant films adsorbed at air-water interfaces.
    Zuo YY; Acosta E; Policova Z; Cox PN; Hair ML; Neumann AW
    Biochim Biophys Acta; 2006 Oct; 1758(10):1609-20. PubMed ID: 16930529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.